McDermott Will & Emery | USA | 21 Dec 2023
On December 14, 2023, Health Resources & Services Administration (HRSA) announced a new resource on the 340B Program website compiling resources…
McDermott Will & Emery | USA | 16 Nov 2023
On November 3, 2023, the US District Court for the District of South Carolina issued a landmark order in Genesis Health Care, Inc. v. Becerra, a case…
Sidley Austin LLP | USA | 6 Nov 2023
Last week, there were three major developments implicating the 340B Drug Pricing Program: (1) a court decision addressing the 340B patient definition…
McDermott Will & Emery | USA | 27 Oct 2023
On October 26, the Health Resources and Services Administration (HRSA) published a Federal Register Notice addressing the use of 340B drugs at…
McDermott Will & Emery | USA | 28 Jun 2023
The Health Resources and Services Administration (HRSA) reminded providers through a program update on Monday, June 5, 2023, that the Provider Relief…
McDermott Will & Emery | USA | 23 Jun 2023
The US Health Resources and Services Administration (HRSA) announced on Monday, June 5, 2023, that it has stopped payments to healthcare providers…
Barnes & Thornburg LLP | USA | 28 Apr 2023
Highlights The Department of Justice announced charges against 18 defendants across nine federal districts in alleged fraud schemes involving health…
Bradley Arant Boult Cummings LLP | USA | 11 Apr 2023
A federal judge has struck down a provision of the Affordable Care Act (ACA) mandating group health plans and insurers to cover a long list of…
Bass Berry & Sims PLC | USA | 13 Jan 2022
On December 28, 2021, the federal government submitted notices to appeal three federal district court decisions related to the use of contract…
K&L Gates LLP | USA | 26 May 2021
On 17 May 2021, the Acting Administrator of the Health Resources and Services Administration (HRSA), Diana Espinosa, sent letters to six…